Amgen Inc. (NASDAQ: AMGN) is one of the world’s largest biotechnology companies, and management plans to update investors on the company’s second quarter financial results on July 27. Will Amgen’s results make this Goliath a stock worth buying?
In this clip from The Motley Fool’s Industry Focus: Healthcare podcast, analyst Kristine Harjes and contributor Todd Campbell discuss what investors should be looking for when management announces their results.